10-K/APeriod: FY1997

BOSTON SCIENTIFIC CORP Annual Report (Amendment), Year Ended Dec 31, 1997

Filed March 31, 1999For Securities:BSX

Summary

This filing is an amendment to Boston Scientific Corp.'s (BSX) 1997 Annual Report (10-K), filed on March 31, 1999. As an amendment, it suggests that the original filing may have contained errors or omissions that are now being corrected. Investors should focus on understanding the nature of the amendments, as they could impact the company's previously reported financial performance, operational status, or risk disclosures for the fiscal year ending December 30, 1997. The filing details are provided through a directory listing of the archived EDGAR data, indicating the availability of the amended document and related files for review. Given the age of the filing, the information pertains to a historical period and should be viewed in the context of BSX's evolution since 1997. Investors interested in this period should consult the actual amended filing document for specific details.

Key Highlights

  • 1The document is an amendment (10-K/A) to Boston Scientific Corp.'s (BSX) 1997 Annual Report.
  • 2The amendment was filed on March 31, 1999, indicating corrections or additions to the original 1997 filing.
  • 3The period ending for the report is December 30, 1997.
  • 4The filing content provided is a directory listing of archived EDGAR data, not the full amended report text.
  • 5This filing relates to historical financial and operational information for BSX from the 1997 fiscal year.
  • 6Investors should seek the actual amended 10-K filing for specific details on the corrections or additions made.

Frequently Asked Questions

This filing is an Amendment to Boston Scientific Corp.'s (BSX) 1997 Annual Report (10-K). It signifies that the company is correcting or supplementing information previously submitted in its original 10-K filing for the fiscal year ending December 30, 1997.

Amendments are typically filed to correct material errors or omissions discovered after the initial filing. The delay could be due to the complexity of the issue being corrected, the time required for investigation, or the process of preparing and filing the corrected information with the SEC.

The provided text is a directory listing of the EDGAR filing. To understand the specific changes, investors need to access the full amended 10-K document (likely the '-99-001689.txt' file or similar) through the SEC's EDGAR database or financial data providers.

This filing pertains to Boston Scientific's financial and operational status in 1997. While it provides historical context, it is unlikely to be directly relevant for current investment decisions, which should focus on the company's most recent filings and its current business environment and performance.